BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1244534)

  • 1. Carrier detection in Duchenne muscular dystrophy.
    Roses AD; Roses MJ; Miller SE; Hull KL; Appel SH
    N Engl J Med; 1976 Jan; 294(4):193-8. PubMed ID: 1244534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pedigree testing in Duchenne muscular dystrophy.
    Roses AD; Roses MJ; Metcalf BS; Hull KL; Nicholson GA; Hartwig GB; Roe CR
    Ann Neurol; 1977 Oct; 2(4):271-8. PubMed ID: 617266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
    Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
    Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminant analysis of ribosomal protein synthesis findings in carrier detection of Duchenne muscular dystrophy.
    Ionasescu V; Burmeister L; Hanson J
    Am J Med Genet; 1980; 5(1):5-12. PubMed ID: 7395900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood myoglobin in children with progressive muscular dystrophy and in carriers].
    Calandi C; Baretti S; Pacciani G; Bagni P; Borsotti M; Tozzi P; Adami Lami C
    Quad Sclavo Diagn; 1984 Dec; 20(4):391-8. PubMed ID: 6537549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
    Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
    Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase.
    Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL
    Am J Med Genet; 1985 Jun; 21(2):291-6. PubMed ID: 3925781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duchenne muscular dystrophy. Morphological study of erythrocytes after treatment with L-alpha-lysophosphatidyl-choline in dystrophic patients and in the carrier state.
    Dellantonio R; Capriotti M; Angeleri F; Curatola G; Mazzanti L; Bertoli E; Lenaz G
    Acta Neurol Belg; 1981; 81(4):193-8. PubMed ID: 7293730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1982 Sep; 13(1):27-38. PubMed ID: 7137219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy].
    Beckmann R; Scheuerbrandt G
    Fortschr Med; 1979 Oct; 97(39):1733-6. PubMed ID: 511067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
    Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
    Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ceruloplasmin in patients with Duchenne muscular dystrophy].
    Reyes J; Holmgren J; Colombo M
    Rev Med Chil; 1991 Mar; 119(3):258-61. PubMed ID: 1842117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1981; 8(4):397-409. PubMed ID: 7246612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.
    Sibert JR; Harper PS; Thompson RJ; Newcombe RG
    Arch Dis Child; 1979 Jul; 54(7):534-7. PubMed ID: 485196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of dystrophin genomic and cDNA probes for solving difficulties in carrier detection and prenatal diagnosis of Duchenne muscular dystrophy.
    Shomrat R; Driks N; Legum C; Shiloh Y
    Am J Med Genet; 1992 Feb; 42(3):281-7. PubMed ID: 1536162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

  • 20. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.